These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 17158282

  • 1. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM.
    Am J Respir Crit Care Med; 2007 Mar 01; 175(5):458-63. PubMed ID: 17158282
    [Abstract] [Full Text] [Related]

  • 2. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
    Watson L, Vonk JM, Löfdahl CG, Pride NB, Pauwels RA, Laitinen LA, Schouten JP, Postma DS, European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
    Respir Med; 2006 Apr 01; 100(4):746-53. PubMed ID: 16199147
    [Abstract] [Full Text] [Related]

  • 3. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM, Sachs AP, Verheij TJ, Salomé PL, Lammers JW, Hoes AW.
    Br J Gen Pract; 2006 Sep 01; 56(530):656-61. PubMed ID: 16953996
    [Abstract] [Full Text] [Related]

  • 4. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P, Ólafsdóttir IS, Benediktsdóttir B, Gíslason T, Janson C.
    Clin Respir J; 2012 Apr 01; 6(2):120-7. PubMed ID: 21651748
    [Abstract] [Full Text] [Related]

  • 5. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
    Baekvad-Hansen M, Dahl M, Tybjaerg-Hansen A, Nordestgaard BG.
    Am J Respir Crit Care Med; 2010 Jan 01; 181(1):17-20. PubMed ID: 19833825
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.
    Rode L, Bojesen SE, Weischer M, Vestbo J, Nordestgaard BG.
    Thorax; 2013 May 01; 68(5):429-35. PubMed ID: 23268483
    [Abstract] [Full Text] [Related]

  • 8. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.
    Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.
    Am J Respir Crit Care Med; 2008 Aug 15; 178(4):332-8. PubMed ID: 18511702
    [Abstract] [Full Text] [Related]

  • 9. Time-dependent confounding in the study of the effects of regular physical activity in chronic obstructive pulmonary disease: an application of the marginal structural model.
    Garcia-Aymerich J, Lange P, Serra I, Schnohr P, Antó JM.
    Ann Epidemiol; 2008 Oct 15; 18(10):775-83. PubMed ID: 18708291
    [Abstract] [Full Text] [Related]

  • 10. Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults.
    Mehta AJ, Miedinger D, Keidel D, Bettschart R, Bircher A, Bridevaux PO, Curjuric I, Kromhout H, Rochat T, Rothe T, Russi EW, Schikowski T, Schindler C, Schwartz J, Turk A, Vermeulen R, Probst-Hensch N, Künzli N, SAPALDIA Team.
    Am J Respir Crit Care Med; 2012 Jun 15; 185(12):1292-300. PubMed ID: 22492989
    [Abstract] [Full Text] [Related]

  • 11. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A, Melbye H.
    Respir Med; 2007 Jun 15; 101(6):1097-105. PubMed ID: 17239575
    [Abstract] [Full Text] [Related]

  • 12. Spirometry, rapid FEV1 decline, and lung cancer among asbestos exposed heavy smokers.
    Chien JW, Au DH, Barnett MJ, Goodman GE.
    COPD; 2007 Dec 15; 4(4):339-46. PubMed ID: 18027161
    [Abstract] [Full Text] [Related]

  • 13. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D, Moschandreas J, Damianaki A, Ntaoukakis E, Siafakas NM, Milic Emili J, Tzanakis N.
    Respir Med; 2007 Jun 15; 101(6):1305-12. PubMed ID: 17112715
    [Abstract] [Full Text] [Related]

  • 14. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
    Casanova C, de Torres JP, Aguirre-Jaíme A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C, Celli BR.
    Am J Respir Crit Care Med; 2011 Nov 01; 184(9):1015-21. PubMed ID: 21836135
    [Abstract] [Full Text] [Related]

  • 15. Reduced lung function predicts increased fatality in future cardiac events. A population-based study.
    Engström G, Hedblad B, Janzon L.
    J Intern Med; 2006 Dec 01; 260(6):560-7. PubMed ID: 17116007
    [Abstract] [Full Text] [Related]

  • 16. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M, Nordestgaard BG, Vestbo J, Lange P.
    Lancet Respir Med; 2013 Sep 01; 1(7):543-50. PubMed ID: 24461615
    [Abstract] [Full Text] [Related]

  • 17. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.
    Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J.
    Eur Respir J; 1997 Apr 01; 10(4):822-7. PubMed ID: 9150319
    [Abstract] [Full Text] [Related]

  • 18. Productive cough is an independent risk factor for the development of COPD in former smokers.
    Yamane T, Hattori N, Kitahara Y, Haruta Y, Sasaki H, Yokoyama A, Kohno N.
    Respirology; 2010 Feb 01; 15(2):313-8. PubMed ID: 20070589
    [Abstract] [Full Text] [Related]

  • 19. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.
    Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G, Romagnoli M, Caramori G, Saetta M, Fabbri LM, Papi A.
    J Allergy Clin Immunol; 2010 Apr 01; 125(4):830-7. PubMed ID: 20227753
    [Abstract] [Full Text] [Related]

  • 20. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
    Thomsen M, Nordestgaard BG, Sethi AA, Tybjærg-Hansen A, Dahl M.
    Eur Respir J; 2012 Mar 01; 39(3):558-66. PubMed ID: 22075484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.